KA
WST icon

Kovack Advisors’s West Pharmaceutical WST Stock Holding History

Kovack Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$888K Buy
+2,468
New +$755K 0.04% 426
2022
Q1 		– Sell
-1,109
Closed -$520K – 832
2021
Q4 		$520K Sell
1,109
-370
-25% -$159K 0.05% 379
2021
Q3 		$628K Buy
1,479
+92
+7% +$38.8K 0.07% 321
2021
Q2 		$498K Sell
1,387
-16
-1% -$5.29K 0.06% 356
2021
Q1 		$395K Sell
1,403
-132
-9% -$37.8K 0.05% 368
2020
Q4 		$435K Buy
+1,535
New +$431K 0.06% 314

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kovack Advisors's WST Position: Q2 2026 in Review

Kovack Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 2,468 shares worth $888K. The stake represents 0.04% of the portfolio and ranks #426 among its holdings. This is a return to the name: Kovack Advisors previously reported a position in WST as recently as Q4 2021.

Kovack Advisors first reported a position in WST in Q4 2020 and has held it in 6 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Kovack Advisors held 2,468 shares of West Pharmaceutical worth $888K as of Q2 2026.
  • West Pharmaceutical was a new Kovack Advisors position in Q2 2026.
  • West Pharmaceutical made up 0.04% of Kovack Advisors's portfolio in Q2 2026, its #426 holding.
  • Kovack Advisors first reported a position in West Pharmaceutical in Q4 2020 and has held it in 6 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.